AU2002246912A1 - Receptor-binding compounds and methods for identifying them - Google Patents

Receptor-binding compounds and methods for identifying them

Info

Publication number
AU2002246912A1
AU2002246912A1 AU2002246912A AU2002246912A AU2002246912A1 AU 2002246912 A1 AU2002246912 A1 AU 2002246912A1 AU 2002246912 A AU2002246912 A AU 2002246912A AU 2002246912 A AU2002246912 A AU 2002246912A AU 2002246912 A1 AU2002246912 A1 AU 2002246912A1
Authority
AU
Australia
Prior art keywords
receptor
identifying
methods
binding compounds
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002246912A
Inventor
Steven A. Kates
John Krstenansky
John J. Nestor Jr.
Christina A. Tan Hehir
Carol J. Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consensus Pharmaceuticals Inc
Original Assignee
Consensus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/813,653 external-priority patent/US20020064770A1/en
Priority claimed from US09/813,651 external-priority patent/US20030018438A1/en
Priority claimed from US09/813,448 external-priority patent/US20020142346A1/en
Application filed by Consensus Pharmaceuticals Inc filed Critical Consensus Pharmaceuticals Inc
Publication of AU2002246912A1 publication Critical patent/AU2002246912A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AU2002246912A 2000-10-27 2001-10-26 Receptor-binding compounds and methods for identifying them Abandoned AU2002246912A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US24358700P 2000-10-27 2000-10-27
US60/243,587 2000-10-27
US09/813,448 2001-03-20
US09/813,653 US20020064770A1 (en) 2000-03-21 2001-03-20 Binding compounds and methods for identifying binding compounds
US09/813,651 2001-03-20
US09/813,653 2001-03-20
US09/813,651 US20030018438A1 (en) 2000-03-21 2001-03-20 Binding compounds and methods for identifying binding compounds
US09/813,448 US20020142346A1 (en) 2000-03-21 2001-03-20 Binding compounds and methods for identifying binding compounds
PCT/US2001/051165 WO2002057313A2 (en) 2000-10-27 2001-10-26 Receptor-binding compounds and methods for identifying them

Publications (1)

Publication Number Publication Date
AU2002246912A1 true AU2002246912A1 (en) 2002-07-30

Family

ID=27500124

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002246912A Abandoned AU2002246912A1 (en) 2000-10-27 2001-10-26 Receptor-binding compounds and methods for identifying them

Country Status (2)

Country Link
AU (1) AU2002246912A1 (en)
WO (1) WO2002057313A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005103721A1 (en) * 2004-04-20 2005-11-03 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with cxc chemokine receptor 4 (cxcr4)
CN103254277B (en) * 2013-05-03 2017-02-08 南京工业大学 Small peptide strengthening mold sequence of strong secretory signal peptide and application thereof
CN113861268A (en) 2014-05-21 2021-12-31 恩特拉达治疗学股份有限公司 Cell penetrating peptides and methods of making and using the same
US10815276B2 (en) 2014-05-21 2020-10-27 Entrada Therapeutics, Inc. Cell penetrating peptides and methods of making and using thereof
WO2016033368A1 (en) 2014-08-27 2016-03-03 Ohio State Innovation Foundation Improved peptidyl calcineurin inhibitors
WO2019148194A2 (en) 2018-01-29 2019-08-01 Ohio State Innovation Foundation Peptidyl inhibitors of calcineurin-nfat interaction
TW201945014A (en) 2018-02-22 2019-12-01 美商安卓達治療股份有限公司 Compositions and methods for treating Mitochondrial Neurogastrointestinal Encephalopathy
US11987647B2 (en) 2018-05-09 2024-05-21 Ohio State Innovation Foundation Cyclic cell-penetrating peptides with one or more hydrophobic residues

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532167A (en) * 1994-01-07 1996-07-02 Beth Israel Hospital Substrate specificity of protein kinases

Also Published As

Publication number Publication date
WO2002057313A8 (en) 2005-10-27
WO2002057313A3 (en) 2003-10-16
WO2002057313A2 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
AU2001241903A1 (en) Snow-gliding apparatus
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
AU2001279850A1 (en) Method and arrangement for studsystem
EP1469316A2 (en) Screening method
AU2001243394A1 (en) Compounds and methods
AU2001267978A1 (en) Method for analyzing words
AU2001265871A1 (en) Substituted sulfonylaminopyrimidines
AU2001254731A1 (en) Substituted phenyluracils
AUPQ872300A0 (en) Compounds and methods
AU2001220281A1 (en) Rollerboard for road-skiing
AU2002246912A1 (en) Receptor-binding compounds and methods for identifying them
AU2002214487A1 (en) Method for inducing apoptiosis
AU2001213027A1 (en) Contents providing method
AU2001266176A1 (en) Methods
AU2001237530A1 (en) Method
AU2001278951A1 (en) Compounds and methods
AU2001241636A1 (en) Halotherapy method
AU2001250536A1 (en) Methods
AU2002235277A1 (en) Compounds and methods
AU2002220757A1 (en) Method for obtaining azaerythromycin
AU2001287754A1 (en) Impactor
AU2002223604A1 (en) Substituted phenyluracils
AU2001215553A1 (en) Contents providing method
AU4667801A (en) Methods

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase